Sort   by:  
 Page size 
UnknownEfficacy and safety of lixisenatide once daily versus exenatide twice daily in type 2 diabetes inadequately controlled on metformin: a 24-week, randomized, open-label, active-controlled study (GetGoal-X).
Not available
S-EPMC3781502 | biostudies-literature
UnknownEffect of Vupanorsen on Non-High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70.
Not available
S-EPMC9047643 | biostudies-literature
UnknownIncidence of unanticipated difficult airway using an objective airway score versus a standard clinical airway assessment: the DIFFICAIR trial - trial protocol for a cluster randomized clinical trial.
Not available
S-EPMC3842741 | biostudies-literature
UnknownEfficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial.
Not available
S-EPMC2565674 | biostudies-literature
UnknownGlycated Albumin Correlates With Time-in-Range Better Than HbA1c or Fructosamine.
Not available
S-EPMC10583977 | biostudies-literature
UnknownDetailed statistical analysis plan for the difficult airway management (DIFFICAIR) trial.
Not available
S-EPMC4030275 | biostudies-literature
UnknownClinical perspectives on the frequency of hypoglycemia in treat-to-target randomized controlled trials comparing basal insulin analogs in type 2 diabetes: a narrative review.
Not available
S-EPMC11097869 | biostudies-literature
UnknownDose-response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial.
Not available
S-EPMC10844353 | biostudies-literature
UnknownInitial combination therapy with alogliptin and pioglitazone in drug-naive patients with type 2 diabetes.
Not available
S-EPMC2963503 | biostudies-literature
UnknownA randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes.
Not available
S-EPMC2235909 | biostudies-literature
Sort   by:  
 Page size